Portasystemic shunt fraction quantification with colonic iodine-123 iodoamphetamine.
1986; National Institutes of Health; Volume: 27; Issue: 8 Linguagem: Inglês
Autores
Chi‐Kwan Yen, Myron Pollycove, Richard A. Crass, Tianye Lin, Ronald M. Baldwin, Joann Lamb,
Tópico(s)Hepatocellular Carcinoma Treatment and Prognosis
ResumoPortasystemic shunting was quantified in dogs with [123I]iodoamphetamine (IMP) administered transrectally into the colon and monitored externally with a gamma camera. IMP was absorbed rapidly and unchanged from the colon. After direct injection into the portal vein, IMP was almost completely extracted by the liver on the first pass, and the washout half-life was approximately 60 min. Based on these kinetic data, computer simulation of this biologic system was carried out. Errors associated with simplified models are calculated. The simplest model with insignificant error, which assumed that the tracer behaved like microspheres, was used to quantitate portasystemic shunt fraction in animals with surgically created shunts. Results were compared with the standard of 99mTc-labeled macroaggregated albumin infused into a branch of inferior mesenteric vein. For shunt fractions ranging from 0 to 100%, an excellent correlation was seen, indicating that this approach is potentially a simple, noninvasive method of portasystemic shunt fraction quantification.
Referência(s)